MedPath

The effect of vitamin C on agitation induced by naltrexone, a randomized clinical trial study

Phase 1
Conditions
agitation.
agitation
Registration Number
IRCT201107046948N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
31
Inclusion Criteria

Patients between ages 18-40; opioid abusers; coming to the hospital with withdrawal symptoms including agitation; caused by misusing of naltrexone. Exclusion criteria: Patients who had an underlying medical disorder (diabetic mellitus, renal failure, cardiovascular disease, renal stone and those undergo dialysis); pregnant women; those who were very agitated and need intubation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agitation. Timepoint: every one hour. Method of measurement: RAAS score.
Secondary Outcome Measures
NameTimeMethod
Rhabdomyolysis. Timepoint: after first 24 hours. Method of measurement: urine analysis.
© Copyright 2025. All Rights Reserved by MedPath